We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

176 hedge funds and large institutions have $1.64B invested in NxStage Medical Inc. in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

3.94% more ownership

Funds ownership: 85.81%89.75% (+3.9%)

3% more funds holding

Funds holding: 171176 (+5)

3% more capital invested

Capital invested by funds: $1.59B → $1.64B (+$49.2M)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

0% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 54

36% less call options, than puts

Call options by funds: $1.97M | Put options by funds: $3.08M

Holders
176
Holders Change
+5
Holders Change %
+2.92%
% of All Funds
4.01%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
28
Increased
54
Reduced
54
Closed
20
Calls
$1.97M
Puts
$3.08M
Net Calls
-$1.11M
Net Calls Change
-$1.04M

NXTM Hedge Fund Activity: Q3 2018 in Review

176 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2018, worth a combined $1.64B — up 3.1% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NXTM positions and 20 closed out — a net gain of 8 holders — while 54 added to existing stakes and 54 trimmed.

The largest buyer was Millennium Management, adding an estimated $34.3M. The largest seller was Flossbach Von Storch, cutting an estimated $46.7M.

  • 176 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2018, up from 171 in Q2 2018.
  • Funds reported $1.64B of NxStage Medical Inc. stock for Q3 2018, up 3.1% quarter-over-quarter.
  • 28 funds opened new NxStage Medical Inc. positions in Q3 2018 and 20 closed out, a net change of +8 holders.
  • The largest NxStage Medical Inc. buyer in Q3 2018 was Millennium Management, an estimated $34.3M added.
  • The largest NxStage Medical Inc. seller in Q3 2018 was Flossbach Von Storch, an estimated $46.7M sold.

Based on aggregated 13F filings for Q3 2018.